143 related articles for article (PubMed ID: 16470676)
1. In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomes.
Kim H; Kang S; Kim H; Yoon YJ; Cha EY; Lee HS; Kim JH; Yea SS; Lee SS; Shin JG; Liu KH
Rapid Commun Mass Spectrom; 2006; 20(5):837-43. PubMed ID: 16470676
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes.
Kim H; Yoon YJ; Kim H; Cha EY; Lee HS; Kim JH; Yi KY; Lee S; Cheon HG; Yoo SE; Lee SS; Shin JG; Liu KH
Arch Pharm Res; 2005 Nov; 28(11):1287-92. PubMed ID: 16350857
[TBL] [Abstract][Full Text] [Related]
3. Enzyme kinetic study of a new cardioprotective agent, KR-32570 using human liver microsomes and recombinant CYP isoforms.
Kim H; Seo KA; Kim H; Lee HS; Lee CH; Shin JG; Liu KH
Arch Pharm Res; 2007 Apr; 30(4):469-74. PubMed ID: 17489363
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of a new neuroprotective agent, KR-31543 in the human liver microsomes: identification of human cytochrome P450.
Ji HY; Lee SS; Yoo SE; Kim H; Lee DH; Lim H; Lee HS
Arch Pharm Res; 2004 Feb; 27(2):239-45. PubMed ID: 15022728
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.
Kim H; Yoon YJ; Kim H; Kang S; Cheon HG; Yoo SE; Shin JG; Liu KH
Toxicol Lett; 2006 Oct; 166(2):105-14. PubMed ID: 16857327
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436.
Ji HY; Lee HW; Kim HH; Choi JK; Lee HS
Toxicol Lett; 2005 Jan; 155(1):103-14. PubMed ID: 15585365
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes.
Joo J; Lee D; Wu Z; Shin JH; Lee HS; Kwon BM; Huh TL; Kim YW; Lee SJ; Kim TW; Lee T; Liu KH
Biopharm Drug Dispos; 2013 May; 34(4):195-202. PubMed ID: 23446989
[TBL] [Abstract][Full Text] [Related]
11. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS identification of in vitro metabolites of a new H+/K+ ATPase inhibitor, KR-60436 produced by rat and human liver microsomes.
Choi SJ; Ji HY; Baek SK; Lee HY; Choi JK; Cheon HG; Lee DH; Lim H; Lee HS
J Pharm Biomed Anal; 2002 Jun; 28(5):897-902. PubMed ID: 12039631
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
14. Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry.
Jing WH; Song YL; Yan R; Wang YT
J Pharm Biomed Anal; 2013 Apr; 77():175-88. PubMed ID: 23434495
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s.
Joo J; Wu Z; Lee B; Shon JC; Lee T; Lee IK; Sim T; Kim KH; Kim ND; Kim SH; Liu KH
Biopharm Drug Dispos; 2015 Apr; 36(3):163-73. PubMed ID: 25451157
[TBL] [Abstract][Full Text] [Related]
16. Identification of human liver cytochrome P450 enzymes responsible for the metabolism of lonafarnib (Sarasar).
Ghosal A; Chowdhury SK; Tong W; Hapangama N; Yuan Y; Su AD; Zbaida S
Drug Metab Dispos; 2006 Apr; 34(4):628-35. PubMed ID: 16443667
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543 in the rat using liquid chromatography/electrospray mass spectrometry.
Kim J; Ji HY; Lee SS; Yoo SE; Kim SO; Lee DH; Lim H; Lee HS
Arch Pharm Res; 2002 Oct; 25(5):664-8. PubMed ID: 12433202
[TBL] [Abstract][Full Text] [Related]
18. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
Prakash C; Wang W; O'Connell T; Johnson KA
Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of a novel PPAR gamma agonist, KR-62980, and its stereoisomer, KR-63198, in human liver microsomes and by recombinant cytochrome P450s.
Kim KB; Seo KA; Yoon YJ; Bae MA; Cheon HG; Shin JG; Liu KH
Xenobiotica; 2008 Sep; 38(9):1165-76. PubMed ID: 18609447
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
